Signaling Pathways - Inflammatory Bowel Disease - Hepatitis C - Chronic Myeloproliferative Disorders - Colon Carcinoma
清除全部
-
B2186 GSK2636771Target: PI3KSummary: PIK3抑制剂 -
B2173 CP-673451Target: PDGFRSummary: PDGFRα/β抑制剂 -
A1877 XAV-9391 CitationTarget: TNKSSummary: Tankyrase 1/2抑制剂 -
A1821 Ki8751Target: VEGFRSummary: VEGFR-2有效的、选择性抑制剂 -
A3820 Simeprevir1 Citation中文名: 西咪匹韦Target: HCV ProteasesSummary: HCV NS3/4A蛋白酶抑制剂 -
A3721 PHA-767491Target: Cyclin-Dependent Kinases|MK2|Cdc7Summary: Cdc7 / CDK9抑制剂 -
A3655 NesbuvirTarget: Nonstructural protein 5B (NS5B)Summary: NS5B聚合酶选择性抑制剂 -
A3209 AXL1717中文名: 鬼臼毒素Target: Insulin-like growth factor receptors(IGFRs)Summary: IGF-1R抑制剂，口服有效。 -
A4010 Salinosporamide A (NPI-0052, Marizomib)Target: ProteasomeSummary: 20S蛋白酶体抑制剂 -
A4212 Pomalidomide (CC-4047)中文名: 泊马度胺Summary: 抗肿瘤/抗血管生成的免疫调制剂